Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide

JY Hor, N Asgari, I Nakashima, SA Broadley… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …

The prevalence of MS in the United States: a population-based estimate using health claims data

MT Wallin, WJ Culpepper, JD Campbell, LM Nelson… - Neurology, 2019 - AAN Enterprises
Objective To generate a national multiple sclerosis (MS) prevalence estimate for the United
States by applying a validated algorithm to multiple administrative health claims (AHC) …

Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

MT Wallin, WJ Culpepper, E Nichols, ZA Bhutta… - The Lancet …, 2019 - thelancet.com
Background Multiple sclerosis is the most common inflammatory neurological disease in
young adults. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) …

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

L Belbasis, V Bellou, E Evangelou… - The Lancet …, 2015 - thelancet.com
Background The cause of multiple sclerosis is believed to involve environmental exposure
and genetic susceptibility. We aimed to summarise the environmental risk factors that have …

Epidemiology of multiple sclerosis

J Howard, S Trevick, DS Younger - Neurologic clinics, 2016 - neurologic.theclinics.com
The Americas In 2007, Poser and Brinar 1 noted that published prevalence rates of multiple
sclerosis (MS) could be misleading with the reliance on clinical information and brain MRI …

Regulatory T cells in multiple sclerosis and myasthenia gravis

KM Danikowski, S Jayaraman… - Journal of …, 2017 - Springer
Multiple sclerosis (MS) is a chronic debilitating disease of the central nervous system
primarily mediated by T lymphocytes with specificity to neuronal antigens in genetically …

[HTML][HTML] Multiple sclerosis, a treatable disease

A Doshi, J Chataway - Clinical Medicine, 2017 - ncbi.nlm.nih.gov
This article reviews our current understanding and modern treatment of multiple sclerosis
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review

D Karussis - Journal of autoimmunity, 2014 - Elsevier
Multiple sclerosis (MS), is a chronic disease of the central nervous system (CNS)
characterized by loss of motor and sensory function, that results from immune-mediated …

Virtual reality in multiple sclerosis rehabilitation: A review on cognitive and motor outcomes

MG Maggio, M Russo, MF Cuzzola, M Destro… - Journal of Clinical …, 2019 - Elsevier
Multiple sclerosis (MS) is a demyelinating neurodegenerative disease with lesions involving
the central nervous system. Clinical symptoms consist of disturbances in motor activity (eg …